CardioDx, Inc., a molecular diagnostics company specializing in cardiovascular genomics, is committed to developing clinically validated tests that empower clinicians to better tailor care to each individual patient. Strategically focused on coronary artery disease, CardioDx is committed to expanding patient access and improving healthcare quality and efficiency through the commercialization of genomic technologies.
Company growth
Type
Private
HQ
Redwood City, US
Founded
2004
Size (employees)
138 (est)-5%
CardioDx was founded in 2004 and is headquartered in Redwood City, US

Key People at CardioDx

David Levison

David Levison

Founder & President & CEO
Andrew Guggenhime

Andrew Guggenhime

CFO
David Chernoff

David Chernoff

Chief Medical Officer
Susan Daniels

Susan Daniels

VP, Development
Gwen Carscadden

Gwen Carscadden

VP, Human Resources
Deborah L. Kilpatrick

Deborah L. Kilpatrick

Chief Commercial Officer

CardioDx Office Locations

CardioDx has offices in Redwood City, Greensboro
Redwood City, US
Greensboro, US

CardioDx Metrics

CardioDx Summary

We estimate that CardioDx's latest funding round in February 2016 was $12.4 M. In total, CardioDx has raised $284 M

CardioDx Online Presence

CardioDx Company Life

You may also be interested in